• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

DHS to ‘explore alternatives’

Article

Imaging services firm Diagnostic Health Services of Dallas has engaged Prudential Securities to help the company explore “various alternatives to maximize DHS shareholder value.” The company did not specify what those alternatives might be, but

Imaging services firm Diagnostic Health Services of Dallas has engaged Prudential Securities to help the company explore “various alternatives to maximize DHS shareholder value.” The company did not specify what those alternatives might be, but they could include either acquisitions or a merger with another firm.

Any acquisitions could be complicated by the recent decline in Diagnostic Health’s share price, however. The plunge of the stock market has cut the value of the company’s stock in half, with DHS shares falling from around $10 a share in July to about $4.50 in mid-September. Shares of the firm were trading as high as $13 a share in late March. The lower value of DHS shares would make it more difficult to use stock as an acquisition vehicle.

Recent Videos
Employing AI in Detecting Subdural Hematomas on Head CTs: An Interview with Jeremy Heit, MD, PhD
Pertinent Insights into the Imaging of Patients with Marfan Syndrome
What New Brain MRI Research Reveals About Cannabis Use and Working Memory Tasks
Current and Emerging Legislative Priorities for Radiology in 2025
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 2
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 2
How Will the New FDA Guidance Affect AI Software in Radiology?: An Interview with Nina Kottler, MD, Part 1
A Closer Look at the New Appropriate Use Criteria for Brain PET: An Interview with Phillip Kuo, MD, Part 1
Teleradiology and Breast Imaging: Keys to Facilitating Personalized Service, Efficiency and Equity
Current and Emerging Insights on AI in Breast Imaging: An Interview with Mark Traill, MD, Part 3
Related Content
© 2025 MJH Life Sciences

All rights reserved.